oral flecainide blocked the accessory pathway in the anterograde direction in 68.7 % , and in the retrograde direction in 62 % of patients , and prevented arrhythmias during provocative testing in 82 % of patients ( 14 out of 17 ) .
C0016229
flecainide
C0003811
arrhythmias